L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
67,200
+600 (0.90%)
Dec 10, 2025, 3:30 PM KST
263.24%
Market Cap1.64T
Revenue (ttm)79.99B
Net Income (ttm)78.00B
Shares Out24.62M
EPS (ttm)3,050.54
PE Ratio21.64
Forward PEn/a
Dividend50.00 (0.08%)
Ex-Dividend DateDec 29, 2025
Volume875,377
Average Volume789,407
Open66,700
Previous Close66,600
Day's Range64,600 - 68,900
52-Week Range18,170 - 80,000
Beta1.08
RSI66.38
Earnings DateNov 14, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.